Reports of a new, mutated coronavirus variant making its rounds in some areas of the United Kingdom has raised doubts that the COVID-19 vaccine could be ineffective towards this strain. Scientists at the Walter Reed Army Institute of Research are exploring the mutation and would be able to share some information in a few days.
The director of the Center for Infectious Diseases Research, Dr. Nelson Michael, has stated that the scientists are anticipating that the vaccine will prove to be effective against the variant. There are concerns regarding the efficacy of the vaccine if there is significant mutation of the variant.
“It stands to reason that this mutation isn’t a threat, but you never know. We still have to be diligent and continue to look,” Michael said.
As a primary step, the scientists are conducting a computer analysis of the genetic sequences of the new variant on Thursday.
“The computer analysis will allow us to gauge how much concern we should have,” Michael said. “Other teams around the world are doing this analysis, too.”
Reports say that if the analysis unveils a cause for concern, the next step would be carrying out studies on animals in a laboratory to record definitive results regarding the effect of the vaccine on the variant.
UK Prime Minister, Boris Johnson, has proclaimed new lockdowns in some areas of the country that have been hit by the new mutation.
This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.
Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.